about
Possible pathophysiology of ketamine-related cystitis and associated treatment strategiesKetamine use: a review.Biological effect of ketamine in urothelial cell lines and global gene expression analysis in the bladders of ketamine‑injected mice.Histopathological assessment of inflammation and expression of inflammatory markers in patients with ketamine-induced cystitis.The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine useIatrogenic changes in the urinary tract.Diagnostically challenging cases: what are atypia and dysplasia?Recreational ketamine: from pleasure to pain.Ketamine as a new treatment for depression: a review of its efficacy and adverse effects.Urological complications of illicit drug use.Ketamine-associated urinary tract dysfunction: an underrecognized clinical entity.Proliferation of the human urothelium is induced by atypical β1 -adrenoceptors.Changes to the bladder epithelial barrier are associated with ketamine-induced cystitis.Nerve hyperplasia: a unique feature of ketamine cystitis.Demonstration of the direct impact of ketamine on urothelium using a tissue engineered bladder model.One-stop clinic for ketamine-associated uropathy: report on service delivery model, patients' characteristics and non-invasive investigations at baseline by a cross-sectional study in a prospective cohort of 318 teenagers and young adults.The effects of recreational ketamine cystitis on urinary tract reconstruction - a surgical challenge.Ketamine cystitis: practical considerations in management.Ketamine uropathy: rising to the challenges of a new condition.
P2860
Q27013111-574EE532-BBB8-4F1A-921C-AD22F3922E83Q34202404-9E608E9D-AE82-4113-A06B-04D382934133Q34673343-4F6B89EF-86DF-45EF-9706-3D7FCB8042AAQ35110940-84FD848D-FA7E-4FFB-B56A-6CB975B2B350Q35200052-565EE245-D509-4D24-A7F1-A4938974711BQ36222426-8E5EBFFF-371C-4352-B44F-52A280C2966CQ37577983-BDDAD182-EAD4-4410-8673-CADA732CC9E0Q37840284-0B1F65CF-FBFC-455C-BD22-095D10E8C64BQ38105535-FAF34C03-0389-42D7-BCD1-F032D1C15550Q38188867-1D13873E-B091-47D8-89CD-420495CEC634Q39246120-DE782D3F-8498-4AD7-8680-D789411C35B3Q39970139-BC687839-18FE-40BD-9E1E-891DE78D531EQ41665026-FC0A5933-062D-4885-875D-F32CDD538392Q41874803-3A60F46A-2537-49E5-A597-FAACC3E09A0FQ42077939-494A7016-A238-4BF2-B60A-58A69D403F36Q43974460-A881829C-1AE8-47C1-960C-56F854ABB156Q47325469-A7A89816-A83C-4613-B201-813B51114D32Q47877869-1EE43D87-6A9C-4BF7-8BB2-A3BABDEC0E5AQ48181356-10051981-789C-4D89-ACBA-B16814577010
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Ketamine cystitis as a mimic of carcinoma in situ.
@en
Ketamine cystitis as a mimic of carcinoma in situ.
@nl
type
label
Ketamine cystitis as a mimic of carcinoma in situ.
@en
Ketamine cystitis as a mimic of carcinoma in situ.
@nl
prefLabel
Ketamine cystitis as a mimic of carcinoma in situ.
@en
Ketamine cystitis as a mimic of carcinoma in situ.
@nl
P2093
P1433
P1476
Ketamine cystitis as a mimic of carcinoma in situ.
@en
P2093
Angela M Cottrell
David Gillatt
Jon D Oxley
Susan Adams
P304
P356
10.1111/J.1365-2559.2009.03437.X
P577
2009-12-01T00:00:00Z